Annual report for Sequent Scientific Ltd. for FY-2023
23-05-2023
SEQUENT SCIENTIFIC LTD. - 512529 - Clarification On Increase In Volume
We refer to your email dated May 17, 2023 vide reference no. L/SURV/ONL/PV/KB/ 2023-2024 /94, seeking clarification on the significant increase in volume of the securities of the Company across exchanges. We wish to clarify that Company has made all the required disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information / event that, in our opinion, would have a bearing on the price / volume behaviour in the scrip.17-05-2023
SEQUENT SCIENTIFIC LTD. - 512529 - Clarification sought from Sequent Scientific Ltd
The Exchange has sought clarification from Sequent Scientific Ltd on May 17, 2023, with reference to Movement in Volume.The reply is awaited.17-05-2023
SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has, as a part of its investors engagement activities, scheduled a conference call with the Analysts / Investors on Wednesday, May 24, 2023, to discuss its Q4FY23 financial results.17-05-2023
SEQUENT SCIENTIFIC LTD. - 512529 - Board Meeting Intimation for Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 ,inter alia, to consider and approve 1. the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2023. 2. dividend for the year ended March 31, 2023, if any.16-05-2023
SEQUENT SCIENTIFIC LTD. - 512529 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company SEQUENT SCIENTIFIC LTD. 2 CIN NO. L99999MH1985PLC036685 3 Report filed for FY 2022-2023 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2020-21, 2021-22 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2020-21, 2021-22 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Krunal ShahDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- PV Raghavendra Rao Designation : -Chief Financial Officer Date: 11/05/202311-05-2023
SEQUENT SCIENTIFIC LTD. - 512529 - Clarification On Increase In Volume
We refer to your email dated April 20, 2023, (L/SURV/ONL/PV/AA/ 2023-2024 / 38), seeking clarification on the significant increase in volume of the securities of the Company across exchanges. We wish to clarify that Company has made all the required disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information / event that, in our opinion, would have a bearing on the price / volume behaviour in the scrip.28-04-2023
SEQUENT SCIENTIFIC LTD. - 512529 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySEQUENT SCIENTIFIC LTD. 2CIN NO.L99999MH1985PLC036685 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 23.30 4Highest Credit Rating during the previous FY A+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Krunal Shah Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: P V Raghavendra Rao Designation: Chief Financial Officer EmailId: [email protected] Date: 27/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.27-04-2023
SEQUENT SCIENTIFIC LTD. - 512529 - Clarification sought from Sequent Scientific Ltd
The Exchange has sought clarification from Sequent Scientific Ltd on April 20, 2023, with reference to Movement in Volume.The reply is awaited.20-04-2023
SEQUENT SCIENTIFIC LTD. - 512529 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a certificate issued in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, by KFin Technologies Limited, the Registrar and Share Transfer Agent of the Company, for the quarter ended 31 March 2023.14-04-2023